Experienced in Pectus Excavatum

Xiangning Y. Fu

No.1095 Jiefang Avenue, 
Wuhan, CN 
Experienced in Pectus Excavatum
No.1095 Jiefang Avenue, 
Wuhan, CN 
OverviewLocationsClinical Research

Overview

Xiangning Fu practices in Wuhan, China. Fu is rated as an Experienced expert by MediFind in the treatment of Pectus Excavatum. Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Thymectomy.

Their clinical research consists of co-authoring 133 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pectus Excavatum.

Locations

No.1095 Jiefang Avenue, Wuhan, 430030, China
Other Locations
No. 1095 Jiefang Avenue, Wuhan, 430030, China
No. 1095 Jiefang Road, Wuhan, 430030, China
1095# Jiefang Avenue, Wuhan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Compare Effectiveness and Safety of the Minimally Invasive Surgeries of Ivor-Lewis and Mckeown in Chinese Patients With IA-IIIB Esophageal Cancer
A Multi-centre Real-world Non-interventional Observational Study to Compare Effectiveness and Safety of the Minimally Invasive Surgeries of Ivor-Lewis and Mckeown in Chinese Patients With IA-IIIB Esophageal Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
View 5 Less Clinical Trials

133 Total Publications

Occult N1 Non-Small Cell Lung Cancer: Why We Need Caution Before Embracing Segmentectomy as Standard.
Occult N1 Non-Small Cell Lung Cancer: Why We Need Caution Before Embracing Segmentectomy as Standard.
Journal: The Annals of thoracic surgery
Published: August 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fu's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile